Glaxo Grp Ltd Drug Patent Portfolio

Glaxo Grp Ltd owns 9 orange book drugs protected by 65 US patents with Advair Diskus 100/50 having the least patent protection, holding only 2 patents. And Flovent Hfa with maximum patent protection, holding 41 patents. Given below is the list of Glaxo Grp Ltd's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8746242 Medicament dispenser 11 Apr, 2031
Active
US8746242 Medicament dispenser 11 Oct, 2030
Active
US8534281 Manifold for use in medicament dispenser 08 Sep, 2030
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
Active
US11116721 Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol 26 Aug, 2029
Active
US11116721 Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol 26 Feb, 2029
Active
US8161968 Medicament dispenser 05 Aug, 2028
Active
US8113199 Counter for use with a medicament dispenser 23 Apr, 2028
Active
US9333310 Medicament dispenser 02 Apr, 2028
Active
US8161968 Medicament dispenser 05 Feb, 2028
Active
US8511304 Medicament dispenser 14 Dec, 2027
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
Active
US9333310 Medicament dispenser 02 Oct, 2027
Active
US8511304 Medicament dispenser 14 Jun, 2027
Active
US7500444 Actuation indicator for a dispensing device 26 Aug, 2026
Active
US7500444 Actuation indicator for a dispensing device 26 Feb, 2026
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 Nov, 2025
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 May, 2025
Active
US7832351 Actuation indicator for a dispensing device 19 Dec, 2023 Expired
US7832351 Actuation indicator for a dispensing device 19 Jun, 2023 Expired
US7361787 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023 Expired
USRE44874 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023 Expired
US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases 11 Sep, 2022 Expired
US6743413 Suspension aerosol formulations 01 Dec, 2021 Expired
US6537983 Anti-inflammatory androstane derivatives 03 Aug, 2021 Expired
US6759398 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US6878698 Anti-inflammatory androstane derivatives 03 Aug, 2021 Expired
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US7629335 Anti-inflammatory androstane derivative 03 Aug, 2021 Expired
US6743413 Suspension aerosol formulations 01 Jun, 2021 Expired
US9861771 Device housing for an aerosol container 11 Oct, 2020 Expired
US7107986 Dispenser with doses' counter 08 Dec, 2019 Expired
US7350676 Valve for aerosol container 24 Feb, 2019 Expired
US6431168 Dispenser with doses′ counter 08 Dec, 2018 Expired
US7350676 Valve for aerosol container 24 Aug, 2018 Expired
US6161724 Indicating device 16 Jul, 2018 Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jul, 2018 Expired
US6938796 Indicating device 16 Jul, 2018 Expired
US6997349 Indicating device 16 Jul, 2018 Expired
US7143908 Indicating device 16 Jul, 2018 Expired
US6170717 Valve for aerosol container 23 Jun, 2018 Expired
US6315173 Valve for aerosol container 23 Jun, 2018 Expired
US6510969 Valve for aerosol container 23 Jun, 2018 Expired
US6966467 Valve for aerosol container 23 Jun, 2018 Expired
US6431168 Dispenser with doses′ counter 08 Jun, 2018 Expired
US7107986 Dispenser with doses' counter 08 Jun, 2018 Expired
US6161724 Indicating device 16 Jan, 2018 Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jan, 2018 Expired
US6938796 Indicating device 16 Jan, 2018 Expired
US6997349 Indicating device 16 Jan, 2018 Expired
US7143908 Indicating device 16 Jan, 2018 Expired
US6170717 Valve for aerosol container 23 Dec, 2017 Expired
US6315173 Valve for aerosol container 23 Dec, 2017 Expired
US6510969 Valve for aerosol container 23 Dec, 2017 Expired
US6966467 Valve for aerosol container 23 Dec, 2017 Expired
US5873360 Inhalation device 23 Aug, 2016 Expired
US5873360 Inhalation device 23 Feb, 2016 Expired
US5674472 Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Apr, 2015 Expired
US5658549 Aerosol formulations containing propellant 134a and fluticasone propionate 19 Feb, 2015 Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Feb, 2015 Expired
US5674472 Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Oct, 2014 Expired
US5658549 Aerosol formulations containing propellant 134a and fluticasone propionate 19 Aug, 2014 Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Aug, 2014 Expired
US6251368 Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Jun, 2013 Expired
US6251368 Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Dec, 2012 Expired


Given below is the list of recent legal activities going on the following drug patents of Glaxo Grp Ltd.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 20 Oct, 2023 US9333310
Payment of Maintenance Fee, 12th Year, Large Entity 21 Sep, 2023 US8161968
Payment of Maintenance Fee, 12th Year, Large Entity 21 Jul, 2023 US8113199
Payment of Maintenance Fee, 12th Year, Large Entity 21 Apr, 2022 US7832351
Payment of Maintenance Fee, 12th Year, Large Entity 21 Apr, 2022 US7832351
Expire Patent 14 Feb, 2022 US9861771
Expire Patent 14 Feb, 2022 US9861771
Payment of Maintenance Fee, 12th Year, Large Entity 20 Jan, 2022 US7776895
Payment of Maintenance Fee, 8th Year, Large Entity 17 Nov, 2021 US8746242
Patent Issue Date Used in PTA Calculation 14 Sep, 2021 US11116721
Recordation of Patent Grant Mailed 14 Sep, 2021 US11116721
Maintenance Fee Reminder Mailed 30 Aug, 2021 US9861771
Maintenance Fee Reminder Mailed 30 Aug, 2021 US9861771
Email Notification 26 Aug, 2021 US11116721
Issue Notification Mailed 25 Aug, 2021 US11116721


Glaxo Grp Ltd's Drug Patent Litigations

Glaxo Grp Ltd's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jul 26, 2001, against patent number US6596260. The petitioner , challenged the validity of this patent, with BRUGGER et al as the respondent. Click below to track the latest information on how companies are challenging Glaxo Grp Ltd's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US6743413 September, 2015 Terminated-Settled
(18 Nov, 2016)
3M Company Mylan Pharmaceuticals Inc.
US6596260 July, 2001 Decision
(25 Sep, 2002)
BRUGGER et al


Glaxo Grp Ltd Drug Patents' Oppositions Filed in EPO

Glaxo Grp Ltd drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 08, 2014, by Vossius & Partner. This opposition was filed on patent number EP03731693A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP06765149A Apr, 2020 ELKINGTON AND FIFE LLP Patent maintained as amended
EP09779096A Feb, 2020 SANDOZ AG Granted and Under Opposition
EP09779096A Feb, 2020 N.V. Nederlandsch Octrooibureau Granted and Under Opposition
EP09779096A Feb, 2020 Teva UK Limited Granted and Under Opposition
EP09779096A Feb, 2020 HGF Limited Granted and Under Opposition
EP09779096A Feb, 2020 Aera A/S Granted and Under Opposition
EP09779096A Feb, 2020 Gill Jennings & Every LLP Granted and Under Opposition
EP09779096A Feb, 2020 Dehns Ltd Granted and Under Opposition
EP09779096A Feb, 2020 Arven Ilac Sanayi Ve Ticaret A.S. Granted and Under Opposition
EP10178947A Jun, 2015 Teva UK Limited Revoked
EP03731693A May, 2014 Teva UK Limited Opposition rejected
EP03731693A May, 2014 Vossius & Partner Opposition rejected


Glaxo Grp Ltd's Family Patents

Glaxo Grp Ltd drugs have patent protection in a total of 34 countries. It's US patent count contributes only to 10.8% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Glaxo Grp Ltd Drug List

Given below is the complete list of Glaxo Grp Ltd's drugs and the patents protecting them.


1. Advair Diskus 100/50

Advair Diskus 100/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 100/50's drug page


2. Advair Diskus 250/50

Advair Diskus 250/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 250/50's drug page


3. Advair Diskus 500/50

Advair Diskus 500/50 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Diskus 500/50's drug page


4. Advair Hfa

Advair Hfa is protected by 41 patents, out of which 37 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7500444
(Pediatric)
Actuation indicator for a dispensing device 26 Aug, 2026
(1 year, 10 months from now)
Active
US7500444 Actuation indicator for a dispensing device 26 Feb, 2026
(1 year, 4 months from now)
Active
US7500444
(Pediatric)
Actuation indicator for a dispensing device 04 Jul, 2025
(8 months from now)
Active
US7500444 Actuation indicator for a dispensing device 04 Jan, 2025
(2 months from now)
Active
US7832351
(Pediatric)
Actuation indicator for a dispensing device 19 Dec, 2023
(9 months ago)
Expired
US7832351 Actuation indicator for a dispensing device 19 Jun, 2023
(1 year, 3 months ago)
Expired
US6743413
(Pediatric)
Suspension aerosol formulations 01 Dec, 2021
(2 years ago)
Expired
US6743413 Suspension aerosol formulations 01 Jun, 2021
(3 years ago)
Expired
US9861771 Device housing for an aerosol container 11 Oct, 2020
(3 years ago)
Expired
US7350676
(Pediatric)
Valve for aerosol container 24 Feb, 2019
(5 years ago)
Expired
US6431168
(Pediatric)
Dispenser with doses′ counter 08 Dec, 2018
(5 years ago)
Expired
US7107986
(Pediatric)
Dispenser with doses' counter 08 Dec, 2018
(5 years ago)
Expired
US7350676 Valve for aerosol container 24 Aug, 2018
(6 years ago)
Expired
US6161724
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6435372
(Pediatric)
Delivery system for a medicament and method for the assembly thereof 16 Jul, 2018
(6 years ago)
Expired
US6938796
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6997349
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US7143908
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6170717
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6315173
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6510969
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6966467
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6431168 Dispenser with doses′ counter 08 Jun, 2018
(6 years ago)
Expired
US7107986 Dispenser with doses' counter 08 Jun, 2018
(6 years ago)
Expired
US6161724 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jan, 2018
(6 years ago)
Expired
US6938796 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6997349 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US7143908 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6170717 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6315173 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6510969 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6966467 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US5674472
(Pediatric)
Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Apr, 2015
(9 years ago)
Expired
US5658549
(Pediatric)
Aerosol formulations containing propellant 134a and fluticasone propionate 19 Feb, 2015
(9 years ago)
Expired
US6596260
(Pediatric)
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Feb, 2015
(9 years ago)
Expired
US5674472 Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Oct, 2014
(10 years ago)
Expired
US5658549 Aerosol formulations containing propellant 134a and fluticasone propionate 19 Aug, 2014
(10 years ago)
Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Aug, 2014
(10 years ago)
Expired
US6251368
(Pediatric)
Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Jun, 2013
(11 years ago)
Expired
US6251368 Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Advair Hfa's drug page


5. Breo Ellipta

Breo Ellipta is protected by 25 patents, out of which 9 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8746242
(Pediatric)
Medicament dispenser 11 Apr, 2031
(6 years from now)
Active
US8746242 Medicament dispenser 11 Oct, 2030
(6 years from now)
Active
US8534281
(Pediatric)
Manifold for use in medicament dispenser 08 Sep, 2030
(5 years from now)
Active
US8534281 Manifold for use in medicament dispenser 08 Mar, 2030
(5 years from now)
Active
US11116721
(Pediatric)
Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol 26 Aug, 2029
(4 years from now)
Active
US11116721 Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol 26 Feb, 2029
(4 years from now)
Active
US8161968
(Pediatric)
Medicament dispenser 05 Aug, 2028
(3 years from now)
Active
US8113199
(Pediatric)
Counter for use with a medicament dispenser 23 Apr, 2028
(3 years from now)
Active
US9333310
(Pediatric)
Medicament dispenser 02 Apr, 2028
(3 years from now)
Active
US8161968 Medicament dispenser 05 Feb, 2028
(3 years from now)
Active
US8511304
(Pediatric)
Medicament dispenser 14 Dec, 2027
(3 years from now)
Active
US8113199 Counter for use with a medicament dispenser 23 Oct, 2027
(3 years from now)
Active
US9333310 Medicament dispenser 02 Oct, 2027
(2 years from now)
Active
US8511304 Medicament dispenser 14 Jun, 2027
(2 years from now)
Active
US7439393
(Pediatric)
Phenethanolamine derivatives for treatment of respiratory diseases 21 Nov, 2025
(1 year, 1 month from now)
Active
US7439393 Phenethanolamine derivatives for treatment of respiratory diseases 21 May, 2025
(7 months from now)
Active
US7361787 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023
(1 year, 6 months ago)
Expired
USRE44874 Phenethanolamine derivatives for treatment of respiratory diseases 23 Mar, 2023
(1 year, 6 months ago)
Expired
US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases 11 Sep, 2022
(2 years ago)
Expired
US6537983 Anti-inflammatory androstane derivatives 03 Aug, 2021
(3 years ago)
Expired
US6759398 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US6878698 Anti-inflammatory androstane derivatives 03 Aug, 2021
(3 years ago)
Expired
US7101866 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US7629335 Anti-inflammatory androstane derivative 03 Aug, 2021
(3 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Breo Ellipta's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Flovent Diskus 100

Flovent Diskus 100 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 100's drug page


7. Flovent Diskus 250

Flovent Diskus 250 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 250's drug page


8. Flovent Diskus 50

Flovent Diskus 50 is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5873360
(Pediatric)
Inhalation device 23 Aug, 2016
(8 years ago)
Expired
US5873360 Inhalation device 23 Feb, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Diskus 50's drug page


9. Flovent Hfa

Flovent Hfa is protected by 41 patents, out of which 37 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7500444
(Pediatric)
Actuation indicator for a dispensing device 26 Aug, 2026
(1 year, 10 months from now)
Active
US7500444 Actuation indicator for a dispensing device 26 Feb, 2026
(1 year, 4 months from now)
Active
US7500444
(Pediatric)
Actuation indicator for a dispensing device 04 Jul, 2025
(8 months from now)
Active
US7500444 Actuation indicator for a dispensing device 04 Jan, 2025
(2 months from now)
Active
US7832351
(Pediatric)
Actuation indicator for a dispensing device 19 Dec, 2023
(9 months ago)
Expired
US7832351 Actuation indicator for a dispensing device 19 Jun, 2023
(1 year, 3 months ago)
Expired
US6743413
(Pediatric)
Suspension aerosol formulations 01 Dec, 2021
(2 years ago)
Expired
US6743413 Suspension aerosol formulations 01 Jun, 2021
(3 years ago)
Expired
US9861771 Device housing for an aerosol container 11 Oct, 2020
(3 years ago)
Expired
US7107986
(Pediatric)
Dispenser with doses' counter 08 Dec, 2019
(4 years ago)
Expired
US7350676
(Pediatric)
Valve for aerosol container 24 Feb, 2019
(5 years ago)
Expired
US6431168
(Pediatric)
Dispenser with doses′ counter 08 Dec, 2018
(5 years ago)
Expired
US7350676 Valve for aerosol container 24 Aug, 2018
(6 years ago)
Expired
US6161724
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6435372
(Pediatric)
Delivery system for a medicament and method for the assembly thereof 16 Jul, 2018
(6 years ago)
Expired
US6938796
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6997349
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US7143908
(Pediatric)
Indicating device 16 Jul, 2018
(6 years ago)
Expired
US6170717
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6315173
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6510969
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6966467
(Pediatric)
Valve for aerosol container 23 Jun, 2018
(6 years ago)
Expired
US6431168 Dispenser with doses′ counter 08 Jun, 2018
(6 years ago)
Expired
US7107986 Dispenser with doses' counter 08 Jun, 2018
(6 years ago)
Expired
US6161724 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6435372 Delivery system for a medicament and method for the assembly thereof 16 Jan, 2018
(6 years ago)
Expired
US6938796 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6997349 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US7143908 Indicating device 16 Jan, 2018
(6 years ago)
Expired
US6170717 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6315173 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6510969 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US6966467 Valve for aerosol container 23 Dec, 2017
(6 years ago)
Expired
US5674472
(Pediatric)
Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Apr, 2015
(9 years ago)
Expired
US5658549
(Pediatric)
Aerosol formulations containing propellant 134a and fluticasone propionate 19 Feb, 2015
(9 years ago)
Expired
US6596260
(Pediatric)
Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Feb, 2015
(9 years ago)
Expired
US5674472 Canisters containing aerosol formulations containing P134a and fluticasone propionate 07 Oct, 2014
(10 years ago)
Expired
US5658549 Aerosol formulations containing propellant 134a and fluticasone propionate 19 Aug, 2014
(10 years ago)
Expired
US6596260 Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol 10 Aug, 2014
(10 years ago)
Expired
US6251368
(Pediatric)
Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Jun, 2013
(11 years ago)
Expired
US6251368 Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant 04 Dec, 2012
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flovent Hfa's drug page